Thomas Wegman, President at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 40,000 shares at $48.04 ($1.9M) on 2016-11-28, disclosed to the SEC on 2016-11-29.
Open-market sale of $1.9M BSTC by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.04 | 11,055 | $531K | 27.6% |
| 2 | $48.04 | 11,055 | $531K | 27.6% |
| 3 | $48.32 | 8,945 | $432K | 22.4% |
| 4 | $48.32 | 8,945 | $432K | 22.4% |
| Total | $48.17 avg | 40,000 | $1.9M | 100% |
| Filing → |
| BSTC | SELL | 2016-12-13 | $743K | — | Filing → |
| BSTC | SELL | 2016-09-16 | $128K | — | Filing → |
| BSTC | SELL | 2016-09-13 | $271K | — | Filing → |